- Lobbying
- horizon AND therapeutics AND fka AND horizon AND pharma AND usa
Lobbying Arrangements Results for 'Horizon Therapeutics Fka Horizon Pharma Usa'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues pertaining to drug pricing and reimbursement, transparency and patient access. S 652 / HR 2620 "Safe Step Act," all provisions. Issues pertaining to the implementation of PL 97-414 "Orphan... |
Horizon Therapeutics USA, Inc. (FKA Horizon Pharma USA, Inc.)
|
in-house lobbying | |||
Details Policies and regulations impacting drugs for rare diseases and conditions; pharmaceutical pricing issues; 340B; Safe Step Act - HR 2630/S 652; FTC regulation of biopharma mergers and acquisitions P... |
HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Lobbying related to business tax reform. |
Horizon Therapeutics USA, Inc.( previously known as Horizon Pharma USA, Inc.)
|
FGS Global (US) LLC (FKA FGH Holdings LLC) | |||
Details H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe step Act |
Amgen, Inc. FKA Horizon Therapeutics USA, Inc.
|
S-3 Group |